Liver Cancer News and Research

RSS

Liver cancer is more common in older people. Over half of people newly diagnosed with liver cancer are age 65 and over. Liver cancer is more common in men than in women. Liver cancer rates are highest among Asians and Pacific Islanders, most likely because of higher prevalence of viral Hepatitis infection. Liver cancer rates are lower among whites than Blacks or Asians and Pacific Islanders. At this time, we do not know exactly what causes cancer of the liver. There are several different types of liver cancer. The most common type is associated with long-term excessive alcoholic beverage use, scarring of the liver (cirrhosis), and Hepatitis B virus or Hepatitis C virus infection. Long-term use of anabolic steroids can also increase the risk of getting liver cancer. Smoking is also believed to increase the risk of getting liver cancer.

Largest hepatitis-C U.S. study defines optimal therapy

Final results of the WIN-R trial,[1] the largest hepatitis C study conducted in U.S. patients, showed that weight-based REBETOL (ribavirin, USP) in combination therapy with PEG-INTRON (peginterferon alfa-2b) achieved significantly higher rates of sustained virologic response (SVR)[2] and lower rates of relapse compared to the combination therapy using a flat dose of ribavirin.

14 Nov 2005

New treatments for health conditions related to abnormal iron metabolism

A new study conducted by scientists at Children's Hospital Oakland Research Institute could help researchers develop new treatments for a variety of health conditions that are all related to abnormal iron metabolism. More than one million Americans have abnormal iron levels in their bodies.

10 Oct 2005

New digital angiography flat panel system reduces the radiation dose to patients undergoing interventional treatment for liver cancer

The study compared the radiation dose to patient's skin during transcatheter arterial embolization, a procedure that blocks the flow of a blood to a tumor. Doses were assessed for 12 patients using a new angiography unit with a digital flat-panel system and 12 using a conventional unit for angiographic imaging.

4 Oct 2005

Gene B-myb essential in preventing tumors

A new study has confirmed that research done with zebrafish may be able to play a critical role in learning about the genetic basis of cancer and the mutations that can lead to it - and identified one gene in particular, B-myb, whose function is essential to preventing tumors.

5 Sep 2005

Study suggests cirrhosis and liver disease nearly inevitable for people with hep C

Nearly 80 percent of chronic hepatitis C sufferers who have the disease for several decades will develop cirrhosis or end-stage liver disease later in life, according to a study published today in the American Gastroenterological Association (AGA) journal Clinical Gastroenterology and Hepatology.

1 Sep 2005

Birth control pill increases risks of cervical and breast cancer

Scientists are now saying that women who take the birth control pill could be increasing their risk of cervical and breast cancer.

31 Jul 2005

Molecular link between a viral infection and development of a common and fatal form of liver cancer

Researchers at The University of Texas M. D. Anderson Cancer Center have uncovered a crucial molecular link between a viral infection and development of a common and fatal form of liver cancer. In the process, they have identified a possible way to treat this disease as well as a number of other cancers.

26 Jul 2005

Provectus to begin clinical trials of new cancer treatment, PV-10

Provectus Pharmaceuticals announced today that it has obtained final clearance to begin the first Phase 1 clinical trial of PV-10, the Company's lead cancer treatment.

21 Jul 2005

Crucial molecular link between a hepatitis B virus (HBV) and hepatocellular carcinoma (HCC)

21 Jul 2005

Biological breakthrough that could offer new hope in the fight against liver cancer

Professor John Mayer and Dr Simon Dawson, in collaboration with colleagues at Japan's Kyoto University, have discovered the function of a new liver oncoprotein - or cancer causing protein - which could be the first step to finding effective new treatments for the deadly illness.

21 Jul 2005

Combination of ribavirin and interferon is more effective in treating hepatitis C than using interferon alone

The researchers reviewed 72 randomized trials and 9,991 patients who had chronic hepatitis C for more than six months and were previously untreated, who had relapsed after treatment or who had not responded to other treatment.

19 Jul 2005

Studies compare hepatitis B drugs

According to a new study Roche's brand of interferon can help control the potentially deadly liver infection, hepatitis B, better than a competitor's drug.

30 Jun 2005

New UK Guidance to be issued on Hepatitis C as 'silent epidemic'

Leading medical experts from throughout the UK will be gathering in Edinburgh today and tomorrow (21-22 April 2004) to arrive at a consensus on how best to treat and manage the 'silent epidemic' of hepatitis C - a virus which is estimated to be carried by over 400,000 people in the UK and which continues to spread globally, as the majority of carriers do not realise they have been infected.

21 Jun 2005

Scientists produce for the first time an infectious form of the hepatitis C virus in laboratory cultures of human cells

The finding, reported in the June 9 issue of Science Express, will allow scientists to study every stage of the HCV life cycle and develop drugs to treat this life-threatening disease that affects more than 170 million people around the world.

9 Jun 2005

Exposure to aflatoxins that contaminate crops in developing countries can be reduced by a simple, cost-effective intervention

Exposure to a cancer-causing toxin that contaminates crops in developing countries can be reduced by a simple, cost-effective intervention on post-harvest storage, concludes a study in this week’s issue of The Lancet.

3 Jun 2005

Global project to combat parasites that cause cancer and infection in millions

Many cancers are associated with infections (for example cervical cancer is linked to the human papilloma virus) but there is no stronger link between a human malignancy and a parasitic infection than that between cancer of the bile ducts and a liver fluke called Opisthorchis viverrini.

18 May 2005

Antiretroviral therapy may prevent excess risk of some cancers in people with HIV

In people infected with human immunodeficiency virus (HIV), highly active anti-retroviral therapy (HAART) may prevent most excess cases of Kaposi sarcoma and non-Hodgkin lymphoma, according to a new study in the March 16 issue of the Journal of the National Cancer Institute.

18 May 2005

Jefferson researcher’s results show promise for metastatic eye melanoma

But now, by simultaneously revving up the immune system and choking off the tumor’s oxygen supply, oncologists at Jefferson Medical College and the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia may have found a better way to battle this deadly cancer.

17 May 2005

Smoking may have a devastating effect on gastrointestinal health

Smoking may have a devastating effect on gastrointestinal health and increase a person's risk of developing pancreatic and liver cancer, according to new research presented today at Digestive Disease Week 2005 (DDW). Furthermore, data from the Nurses' Health Study shows that meat intake and smoking play a part in significantly increasing a woman's risk of colorectal cancer.

17 May 2005

More health benefits from green tea

Green tea appears to protect against cancer by affecting a "promiscuous" protein that pharmaceutical experts are already targeting in an effort to develop a new drug to stop the disease, scientists at the University of Rochester Medical Center have found.

16 May 2005

Liver Cancer News and Research

Further Reading

Largest hepatitis-C U.S. study defines optimal therapy

New treatments for health conditions related to abnormal iron metabolism

New digital angiography flat panel system reduces the radiation dose to patients undergoing interventional treatment for liver cancer

Gene B-myb essential in preventing tumors

Study suggests cirrhosis and liver disease nearly inevitable for people with hep C

Birth control pill increases risks of cervical and breast cancer

Molecular link between a viral infection and development of a common and fatal form of liver cancer

Provectus to begin clinical trials of new cancer treatment, PV-10

Crucial molecular link between a hepatitis B virus (HBV) and hepatocellular carcinoma (HCC)

Biological breakthrough that could offer new hope in the fight against liver cancer

Combination of ribavirin and interferon is more effective in treating hepatitis C than using interferon alone

Studies compare hepatitis B drugs

New UK Guidance to be issued on Hepatitis C as 'silent epidemic'

Scientists produce for the first time an infectious form of the hepatitis C virus in laboratory cultures of human cells

Exposure to aflatoxins that contaminate crops in developing countries can be reduced by a simple, cost-effective intervention

Global project to combat parasites that cause cancer and infection in millions

Antiretroviral therapy may prevent excess risk of some cancers in people with HIV

Jefferson researcher’s results show promise for metastatic eye melanoma

Smoking may have a devastating effect on gastrointestinal health

More health benefits from green tea

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News